Aptose Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aptose Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Aptose Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $756K, a 32.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $756K -$370K -32.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $850K -$368K -30.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $943K -$354K -27.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $1.04M +$815K +370% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.13M +$795K +240% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.22M +$776K +176% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.3M +$832K +179% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $220K -$359K -62% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $331K -$367K -52.6% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $442K -$366K -45.3% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $465K -$460K -49.7% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $579K -$462K -44.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $698K -$449K -39.1% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $808K -$454K -36% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $925K -$451K -32.8% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $1.04M -$450K -30.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $1.15M -$426K -27.1% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $1.26M -$418K -24.9% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $1.38M -$194K -12.4% Dec 31, 2019 10-K 2021-03-23
Q3 2019 $1.49M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.57M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.68M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.57M Jan 1, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.